(Q38235268)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Immune responses during cutaneous and visceral leishmaniasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

main subject

visceral leishmaniasis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Krystal J Evans

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

30 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

1-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

IL-4-deficient Balb/c mice resist infection with Leishmania major

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Participation of natural killer cells in the recovery of mice from visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Dichotomy of protective cellular immune responses to human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Leishmaniasis: current treatment and prospects for new drugs and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Leishmania vaccines: progress and problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Phagosomes are competent organelles for antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Modulation of dendritic cell function by Leishmania parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Leishmaniasis in Sudan. Visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Altered immune responses in mice lacking inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

SIR2-deficient Leishmania infantum induces a defined IFN-gamma/IL-10 pattern that correlates with protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Interleukin 9 and its receptor: an overview of structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Requirements for Th1-dependent immunity against infection with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Molecular phylogeny within type I cytokines and their cognate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The immunology of susceptibility and resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

CD8 cytotoxic T cells in cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The role of nitric oxide in innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Macrophage deactivation by interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

SLC11A1 (formerly NRAMP1) and disease resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Complexities of assessing the disease burden attributable to leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The regulation of immunity to Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Natural killer cell behavior in lymph nodes revealed by static and real-time imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Tumor necrosis factor-alpha: central regulatory cytokine in the induction of macrophage antimicrobial activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

The dynamics of granuloma formation in experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

IL-13 is a susceptibility factor for Leishmania major infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Skin mast cells control T cell-dependent host defense in Leishmania major infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Macrophage and Leishmania: an unacceptable coexistence

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Balancing immunity and pathology in visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CD4+CD25+T Cells in Skin Lesions of Patients with Cutaneous Leishmaniasis Exhibit Phenotypic and Functional Characteristics of Natural Regulatory T Cells

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Cell biology and immunology of Leishmania

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Susceptibility to Leishmania major infection in interleukin-4-deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmaniasis, an emerging infection in travelers

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmania donovani-induced expression of signal regulatory protein alpha on Kupffer cells enhances hepatic invariant NKT-cell activation

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Organ-specific immune responses associated with infectious disease

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmaniasis vaccines: past, present and future

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Natural regulatory T cells in infectious disease

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmaniasis among organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Migratory dermal dendritic cells act as rapid sensors of protozoan parasites

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Keratinocytes determine Th1 immunity during early experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Interleukin-12: a cytokine at the interface of inflammation and immunity

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Marginal zone B cells regulate antigen-specific T cell responses during infection.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Different cytokines are required for induction and maintenance of the Th2 type response in DBA/2 mice resistant to infection with Leishmania major

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

The duration of antigenic stimulation determines the fate of naive and effector T cells.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Silent infection of bone marrow-derived dendritic cells byLeishmania mexicana amastigotes

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Polarized helper-T-cell responses against Leishmania major in the absence of B cells.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Interleukin 17 production among patients with American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CD8 T cell exhaustion in human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Dendritic cells, but not macrophages, produce IL-12 immediately followingLeishmania donovani infection

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

The TGF-beta response to Leishmania chagasi in the absence of IL-12

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

T(H)1 cells control themselves by producing interleukin-10.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

The role of IL-10 in promoting disease progression in leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Decreased IL-10 and IL-13 production and increased CD44hi T cell recruitment contribute to Leishmania major immunity induced by non-persistent parasites.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Transforming growth factor-beta regulation of immune responses

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

The innate immune response against Leishmania parasites.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Tissue granuloma structure-function in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania mexicana and Leishmania amazonensis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

The fate of heterologous CD4+ T cells during Leishmania donovani infection.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Role of chemokines in regulation of immunity against leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-10 mediates susceptibility to Leishmania donovani infection.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

How neutrophils kill microbes

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Invariant NKT cells are essential for the regulation of hepatic CXCL10 gene expression during Leishmania donovani infection

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Interleukin-23: immunological roles and clinical implications

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Development of Th1-type immune responses requires the type I cytokine receptor TCCR

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Early IL-4 production does not predict susceptibility to Leishmania major

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

IL-12 and IL-23: master regulators of innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1017%2FS003118201400095X

7 January 2021

10.1017/S003118201400095X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25075460%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference